Myophil Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Dasatinib

Indications/Uses

Adult patient w/ newly diagnosed Philadelphia chromosome +ve (Ph+) chronic myeloid leukemia (CML) in chronic phase; chronic, accelerated, myloid or lymphoid blast phase CML w/ resistance or intolerance to prior therapy including imatinib; Philadelphia chromosome +ve acute lymphoblastic leukemia (Ph+ ALL) w/ resistance or intolerance to prior therapy. Ped patients w/ newly diagnosed Ph+ CML in chronic phase or Ph+ CML-CP resistant or intolerant to prior therapy including imatinib; newly diagnosed Ph+ ALL in combination w/ chemotherapy.

Dosage/Direction for Use

Adult Chronic phase CML 100 mg once daily. Accelerated phase CML, myeloid/lymphoid blast phase CML or Ph+ ALL 140 ng once daily. Ped CML or Ph+ ALL At least 45 kg 100 mg once daily, 30-<45 kg 70 mg once daily, 20-<30 kg 60 mg once daily, 10-<20 kg 40 mg once daily. Ph+ ALL Begin therapy on or before day 15 of induction chemotherapy when diagnosis is confirmed & continue for 2 yr.

Administration

May be taken with or without food: Swallow whole, do not crush/cut/chew.

Contraindications

Hypersensitivity.

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EA02 - dasatinib ; Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Myophil FC tab 20 mg

Packing/Price

1's

Form

Myophil FC tab 50 mg

Packing/Price

1's

Form

Myophil FC tab 70 mg

Packing/Price

1's

Myophil

dasatinib

Manufacturer:

Biocon Pharma